Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04585399 · ClinicalTrials.gov registry record · NA

Increasing MAT Engagement With Financial Incentives

A NA study, sponsored by Rowan University.

Completed
Registry status
NA
Development phase
92
Enrollment target

NCT04585399 is a NA study that has completed, run by Rowan University. The registered enrollment target is 92 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04585399, a NA study, has completed, sponsored by Rowan University.

COMPLETED
Registry status
NA
Development phase
92 participants
Enrollment target

Study Summary

The increased prevalence of opioid use disorder (OUD) and associated overdoses and adverse events has led to a substantial increase in the number of patients being seen at emergency departments (ED). Thus, the ED may be an ideal location for identifying patients in need of OUD treatment and can serve as the first touch point in the OUD continuum of care to promote medication assisted treatment initiation. Contingency management (CM) is an effective method for promoting treatment initiation and adherence that has not been thoroughly evaluated for this purpose. The primary aim of the current study is to develop and assess the effectiveness, acceptability, and feasibility of a protocol for delivering CM to increase combined buprenorphine + nalaxone (referred to as BUP hereafter) initiation and continuous adherence for OUD in an existing ED "bridge" program (e.g., Bridge plus CM; B+CM) relative to standard care. Secondary objectives include identifying behavioral and neuropsychological correlates to treatment outcomes, including delay discounting, reinforcer demand, and neurological soft signs.

Interventions

  • BEHAVIORAL Contingency management

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2020-01-27
Est. Completion 2024-11-01
Phase NA

Sponsor

Rowan University

19 total trials

What the Registry Record Tells You About NCT04585399

The ClinicalTrials.gov registry entry for NCT04585399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rowan University, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Contingency management is the first listed.

NCT04585399 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04585399 about?

NCT04585399 is a clinical study titled "Increasing MAT Engagement With Financial Incentives". The increased prevalence of opioid use disorder (OUD) and associated overdoses and adverse events has led to a substantial increase in the number of patients being seen at emergency departments (ED). Thus, the ED may be an ideal location for identifying patients in need of OUD treatment and can serv...

What is the current status of trial NCT04585399?

This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2020-01-27. Estimated completion is 2024-11-01.

What interventions are being tested in trial NCT04585399?

The interventions under investigation include: Contingency management (BEHAVIORAL).

Who is sponsoring clinical trial NCT04585399?

This trial is sponsored by Rowan University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.